Director P. Sandler met with representatives of pharmaceutical company MSD. The discussion focused on economic security aspects, resilience of EU supply chains and pharma sector regulatory developments. (Lobbyradar DE, 2026)
Daten unter CC-BY-SA 4.0; Quellen siehe Detailseite.